Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide. It offers clinical services that provides development and consulting services to clinical pharmacology and clinical development spectrum. The company also offers delivery models that include full service, functional service provider, and hybrid service structures. In addition, it delivers phase I  IV clinical trial management, clinical pharmacology, and consulting services. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.

Fortrea Holdings Inc.

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Stoke Therapeutics (STOK), Fortrea Holdings Inc. (FT...

Analysts Are Bullish on These Healthcare Stocks: Stoke Therapeutics (STOK), Fortrea Holdings Inc. (FTRE)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Bicycle Therapeutics (BCYC), Alnylam Pharma (ALNY) and Fortrea Ho...

Analysts Offer Insights on Healthcare Companies: Bicycle Therapeutics (BCYC), Alnylam Pharma (ALNY) and Fortrea Holdings Inc. (FTRE)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Teladoc (TDOC), Fortrea Holdings Inc. (FTRE) and u...

Analysts Offer Insights on Healthcare Companies: Teladoc (TDOC), Fortrea Holdings Inc. (FTRE) and uniQure (QURE)

Fortrea Holdings Inc. ( ($FTRE) ) just unveiled an announcement. On July 27, 2026, Fortrea’s board appointed current director David Smith as interi...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	FTRE	$17.93	+2.96%	353.19K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	FTRE	$17.93	+3.0%	353.19K
3
4
5
6

FTRE

Get Fortrea Holdings Inc. Data in Excel

Get Fortrea Holdings Inc. Data in Excel